Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis

•Benign metastasizing leiomyomatosis (BML) is a rare condition.•Treatment options have traditionally included surgical resection or hormonal based therapy.•Traditional chemotherapy for BML is ineffective.•Our patient has had a prolonged response of stable disease with the anti-VEGF therapy of bevacizumab.